GBA1 and Parkinson disease: The reported milder phenotype of double LRRK2 and GBA1 variant carriers vs. GBA-PD further complicates this interrelationship but at the same time, provides additional evidence for bidirectional modulation and potential for broader use of specifically targeted therapeutics.